Ginkgo Non Operating Income Net Other vs Tax Provision Analysis

DNA Stock

USD 0.86 0.08 10.26%

Ginkgo Bioworks financial indicator trend analysis is much more than just examining Ginkgo Bioworks Holdings latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Ginkgo Bioworks Holdings is a good investment. Please check the relationship between Ginkgo Bioworks Non Operating Income Net Other and its Tax Provision accounts. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

Non Operating Income Net Other vs Tax Provision

Non Operating Income Net Other vs Tax Provision Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Ginkgo Bioworks Holdings Non Operating Income Net Other account and Tax Provision. At this time, the significance of the direction appears to have strong relationship.

The correlation between Ginkgo Bioworks' Non Operating Income Net Other and Tax Provision is 0.71. Overlapping area represents the amount of variation of Non Operating Income Net Other that can explain the historical movement of Tax Provision in the same time period over historical financial statements of Ginkgo Bioworks Holdings, assuming nothing else is changed. The correlation between historical values of Ginkgo Bioworks' Non Operating Income Net Other and Tax Provision is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Operating Income Net Other of Ginkgo Bioworks Holdings are associated (or correlated) with its Tax Provision. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Tax Provision has no effect on the direction of Non Operating Income Net Other i.e., Ginkgo Bioworks' Non Operating Income Net Other and Tax Provision go up and down completely randomly.

Correlation Coefficient

0.71

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Non Operating Income Net Other

Tax Provision

The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.

Most indicators from Ginkgo Bioworks' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Ginkgo Bioworks Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

The current year's Selling General Administrative is expected to grow to about 604 M, whereas Tax Provision is projected to grow to (13.9 M).

	2021	2022	2023	2024 (projected)
Gross Profit	184.1M	273.5M	142.6M	157.4M
Total Revenue	313.8M	477.7M	251.5M	258.2M

Gross Profit Total Revenue

Ginkgo Bioworks fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets
Total Assets		0.82	0.96	0.95	1.0	0.85	0.93	0.87	-0.8	-0.86	0.65	0.96	0.9	0.75	0.84	0.96	0.82	0.92	0.72	-0.64	0.98	0.87	0.68	0.93	0.98	0.96
Short Long Term Debt Total	0.82		0.72	0.84	0.79	0.44	0.78	0.99	-0.34	-0.83	0.57	0.63	0.99	0.68	0.82	0.63	0.39	0.95	0.69	-0.88	0.93	0.81	0.95	0.88	0.91	0.63
Other Current Liab	0.96	0.72		0.94	0.96	0.94	0.97	0.76	-0.85	-0.88	0.59	0.96	0.8	0.57	0.86	0.96	0.81	0.89	0.83	-0.61	0.91	0.9	0.53	0.94	0.93	0.95
Total Current Liabilities	0.95	0.84	0.94		0.93	0.81	0.97	0.88	-0.69	-0.94	0.79	0.88	0.9	0.57	0.93	0.88	0.71	0.95	0.78	-0.75	0.94	0.92	0.64	0.98	0.97	0.87
Total Stockholder Equity	1.0	0.79	0.96	0.93		0.86	0.91	0.84	-0.83	-0.83	0.63	0.97	0.87	0.76	0.82	0.97	0.85	0.89	0.69	-0.6	0.96	0.85	0.65	0.91	0.97	0.97
Other Liab	0.85	0.44	0.94	0.81	0.86		0.87	0.51	-0.96	-0.71	0.49	0.95	0.55	0.46	0.68	0.95	0.89	0.68	0.7	-0.32	0.73	0.75	0.23	0.77	0.76	0.94
Net Tangible Assets	0.93	0.78	0.97	0.97	0.91	0.87		0.82	-0.74	-0.91	0.64	0.89	0.84	0.53	0.88	0.89	0.72	0.94	0.86	-0.68	0.91	0.9	0.59	0.98	0.94	0.88
Property Plant And Equipment Net	0.87	0.99	0.76	0.88	0.84	0.51	0.82		-0.42	-0.85	0.66	0.7	1.0	0.7	0.85	0.7	0.48	0.96	0.67	-0.86	0.95	0.83	0.91	0.9	0.95	0.7
Net Debt	-0.8	-0.34	-0.85	-0.69	-0.83	-0.96	-0.74	-0.42		0.53	-0.41	-0.94	-0.46	-0.58	-0.5	-0.94	-0.96	-0.55	-0.49	0.12	-0.67	-0.58	-0.16	-0.63	-0.68	-0.94
Retained Earnings	-0.86	-0.83	-0.88	-0.94	-0.83	-0.71	-0.91	-0.85	0.53		-0.68	-0.76	-0.87	-0.36	-1.0	-0.76	-0.49	-0.93	-0.9	0.89	-0.88	-0.99	-0.66	-0.95	-0.91	-0.76
Accounts Payable	0.65	0.57	0.59	0.79	0.63	0.49	0.64	0.66	-0.41	-0.68		0.55	0.66	0.34	0.71	0.55	0.54	0.65	0.34	-0.55	0.62	0.61	0.33	0.67	0.67	0.57
Cash	0.96	0.63	0.96	0.88	0.97	0.95	0.89	0.7	-0.94	-0.76	0.55		0.73	0.69	0.74	1.0	0.91	0.79	0.67	-0.45	0.88	0.8	0.47	0.84	0.89	1.0
Non Current Assets Total	0.9	0.99	0.8	0.9	0.87	0.55	0.84	1.0	-0.46	-0.87	0.66	0.73		0.71	0.87	0.73	0.52	0.97	0.7	-0.85	0.97	0.85	0.9	0.92	0.96	0.73
Non Currrent Assets Other	0.75	0.68	0.57	0.57	0.76	0.46	0.53	0.7	-0.58	-0.36	0.34	0.69	0.71		0.34	0.69	0.7	0.62	0.19	-0.26	0.75	0.37	0.68	0.54	0.71	0.69
Other Assets	0.84	0.82	0.86	0.93	0.82	0.68	0.88	0.85	-0.5	-1.0	0.71	0.74	0.87	0.34		0.74	0.47	0.92	0.87	-0.9	0.87	0.99	0.66	0.94	0.9	0.74
Cash And Short Term Investments	0.96	0.63	0.96	0.88	0.97	0.95	0.89	0.7	-0.94	-0.76	0.55	1.0	0.73	0.69	0.74		0.91	0.79	0.67	-0.45	0.88	0.8	0.47	0.84	0.89	1.0
Net Receivables	0.82	0.39	0.81	0.71	0.85	0.89	0.72	0.48	-0.96	-0.49	0.54	0.91	0.52	0.7	0.47	0.91		0.56	0.36	-0.1	0.69	0.51	0.21	0.62	0.7	0.92
Good Will	0.92	0.95	0.89	0.95	0.89	0.68	0.94	0.96	-0.55	-0.93	0.65	0.79	0.97	0.62	0.92	0.79	0.56		0.83	-0.85	0.97	0.92	0.82	0.98	0.98	0.79
Common Stock Shares Outstanding	0.72	0.69	0.83	0.78	0.69	0.7	0.86	0.67	-0.49	-0.9	0.34	0.67	0.7	0.19	0.87	0.67	0.36	0.83		-0.79	0.75	0.92	0.56	0.87	0.77	0.65
Long Term Debt Total	-0.64	-0.88	-0.61	-0.75	-0.6	-0.32	-0.68	-0.86	0.12	0.89	-0.55	-0.45	-0.85	-0.26	-0.9	-0.45	-0.1	-0.85	-0.79		-0.76	-0.87	-0.81	-0.81	-0.76	-0.44
Non Current Liabilities Total	0.98	0.93	0.91	0.94	0.96	0.73	0.91	0.95	-0.67	-0.88	0.62	0.88	0.97	0.75	0.87	0.88	0.69	0.97	0.75	-0.76		0.88	0.82	0.95	1.0	0.88
Capital Surpluse	0.87	0.81	0.9	0.92	0.85	0.75	0.9	0.83	-0.58	-0.99	0.61	0.8	0.85	0.37	0.99	0.8	0.51	0.92	0.92	-0.87	0.88		0.65	0.94	0.9	0.79
Other Current Assets	0.68	0.95	0.53	0.64	0.65	0.23	0.59	0.91	-0.16	-0.66	0.33	0.47	0.9	0.68	0.66	0.47	0.21	0.82	0.56	-0.81	0.82	0.65		0.71	0.78	0.46
Other Stockholder Equity	0.93	0.88	0.94	0.98	0.91	0.77	0.98	0.9	-0.63	-0.95	0.67	0.84	0.92	0.54	0.94	0.84	0.62	0.98	0.87	-0.81	0.95	0.94	0.71		0.97	0.83
Total Liab	0.98	0.91	0.93	0.97	0.97	0.76	0.94	0.95	-0.68	-0.91	0.67	0.89	0.96	0.71	0.9	0.89	0.7	0.98	0.77	-0.76	1.0	0.9	0.78	0.97		0.89
Total Current Assets	0.96	0.63	0.95	0.87	0.97	0.94	0.88	0.7	-0.94	-0.76	0.57	1.0	0.73	0.69	0.74	1.0	0.92	0.79	0.65	-0.44	0.88	0.79	0.46	0.83	0.89

Click cells to compare fundamentals

Ginkgo Bioworks Account Relationship Matchups

Ginkgo Bioworks Investors Sentiment

The influence of Ginkgo Bioworks' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Ginkgo. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Ginkgo Bioworks' public news can be used to forecast risks associated with an investment in Ginkgo. The trend in average sentiment can be used to explain how an investor holding Ginkgo can time the market purely based on public headlines and social activities around Ginkgo Bioworks Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Ginkgo Bioworks' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Ginkgo Bioworks' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Ginkgo Bioworks' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Ginkgo Bioworks.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Ginkgo Bioworks in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Ginkgo Bioworks' short interest history, or implied volatility extrapolated from Ginkgo Bioworks options trading.

Pair Trading with Ginkgo Bioworks

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Ginkgo Bioworks position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ginkgo Bioworks will appreciate offsetting losses from the drop in the long position's value.

Moving against Ginkgo Stock

0.67	ACB	Aurora Cannabis Sell-off Trend	Pair Corr
0.66	ELYM	Eliem Therapeutics Upward Rally	Pair Corr
0.65	CGC	Canopy Growth Corp Financial Report 27th of June 2024	Pair Corr
0.58	HCWB	HCW Biologics	Pair Corr
0.54	KRYS	Krystal Biotech Financial Report 13th of May 2024	Pair Corr

The ability to find closely correlated positions to Ginkgo Bioworks could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ginkgo Bioworks when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ginkgo Bioworks - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ginkgo Bioworks Holdings to buy it.

The correlation of Ginkgo Bioworks is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Ginkgo Bioworks moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Ginkgo Bioworks Holdings moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Ginkgo Bioworks can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:

How To Invest In Ginkgo

Details

Is Ginkgo Stock a good investment?

Details

What is Ginkgo Bioworks' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Ginkgo Bioworks Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors.

You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for Ginkgo Stock analysis

When running Ginkgo Bioworks' price analysis, check to measure Ginkgo Bioworks' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ginkgo Bioworks is operating at the current time. Most of Ginkgo Bioworks' value examination focuses on studying past and present price action to predict the probability of Ginkgo Bioworks' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ginkgo Bioworks' price. Additionally, you may evaluate how the addition of Ginkgo Bioworks to your portfolios can decrease your overall portfolio volatility.

	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Global Correlations Find global opportunities by holding instruments from different markets
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios

Is Ginkgo Bioworks' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.46)

Revenue Per Share

0.129

Quarterly Revenue Growth

(0.65)

Return On Assets

(0.22)

Return On Equity

(0.63)

The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Ginkgo Non Operating Income Net Other vs Tax Provision Analysis

Non Operating Income Net Other vs Tax Provision

Non Operating Income Net Other vs Tax Provision Correlation Analysis

Correlation Coefficient

Non Operating Income Net Other

Tax Provision

Ginkgo Bioworks fundamental ratios Correlations

Ginkgo Bioworks Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Ginkgo Bioworks Investors Sentiment

Pair Trading with Ginkgo Bioworks

Moving against Ginkgo Stock

Complementary Tools for Ginkgo Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Liab	+ 1.0	Non Current Liabilities Total

Other Assets	- 1.0	Retained Earnings
Capital Surpluse	- 0.99	Retained Earnings
Net Receivables	- 0.96	Net Debt
Net Debt	- 0.96	Other Liab
Other Stockholder Equity	- 0.95	Retained Earnings
Total Current Assets	- 0.94	Net Debt